×
About 775 results

ALLMedicine™ Calciphylaxis Center

Research & Reviews  272 results

Chronic inflammation and calciphylaxis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058681
BMJ Case Reports; Byers A, Herrera N et. al.

Apr 30th, 2022 - Calciphylaxis also known as calcific uraemic arteriolopathy is a rare condition mostly seen in patients with end-stage kidney disease. We report a case of a simultaneous-kidney-pancreas transplant patient with functioning grafts developing biopsy-...

Calciphylaxis a Giant Cell Arteritis Mimic: A Case Report and Review of the Literature.
https://doi.org/10.1097/WNO.0000000000001395
Journal of Neuro-ophthalmology : the Official Journal of ... Duong AA, Bhat N et. al.

Apr 28th, 2022 - Calciphylaxis a Giant Cell Arteritis Mimic: A Case Report and Review of the Literature.|2022|Duong AA,Bhat N,Bindiganavile SH,Chevez-Barrios P,Lee AG,|diagnosis,etiology,complications,diagnosis,

Cutaneous vascular calcification. Perieccrine calcification as a diagnostic key for cal...
https://doi.org/10.1111/cup.14234
Journal of Cutaneous Pathology; Reolid A, Martínez-Palazuelo M et. al.

Apr 1st, 2022 - Attempts have been made to establish discriminative criteria between classic calciphylaxis (CPX) and those cases in which cutaneous vascular calcification (CVC) represents an incidental finding (epiphenomenon). Retrospective, observational cohort ...

Sodium thiosulfate acts as a hydrogen sulfide mimetic to prevent intimal hyperplasia vi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941337
EBioMedicine Macabrey D, Longchamp A et. al.

Mar 26th, 2022 - Intimal hyperplasia (IH) remains a major limitation in the long-term success of any type of revascularisation. IH is due to vascular smooth muscle cell (VSMC) dedifferentiation, proliferation and migration. The gasotransmitter Hydrogen Sulfide (H2...

Concurrent development of encapsulating peritoneal sclerosis and calciphylaxis in a pat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943729
BMJ Case Reports; Win KM, Castelhano R et. al.

Mar 25th, 2022 - Both encapsulating peritoneal sclerosis (EPS) and calciphylaxis are rare but severe complications involving patients with end-stage renal disease. In this report, we discuss a unique case of a 73-year-old female patient who had undergone 8 years o...

see more →

Clinicaltrials.gov  12 results

A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
https://clinicaltrials.gov/ct2/show/NCT05285787

Mar 18th, 2022 - Patients with End Stage Renal Disease (ESRD) are prone to early and accelerated vascular calcification. Both the prevalence and extent of the vascular calcification are predictive for cardiovascular morbidity and all-cause mortality in this popula...

Phase 3 Study of SNF472 for Calciphylaxis
https://clinicaltrials.gov/ct2/show/NCT04195906

Nov 11th, 2021 - The formation and growth of calcified deposits in arterioles and other small blood vessels appears to be fundamental to the development of CUA especially in end stage renal disease patients. This phase 3 double-blind, randomized, placebo-controlle...

Impact of Parathyroidectomy on Vascular Calcification and Clinical Outcome in Hemodialysis Patients
https://clinicaltrials.gov/ct2/show/NCT03724188

Oct 5th, 2021 - All patients above the age of 18, with end stage renal disease maintained on regular hemodialysis and are indicated for surgical parathyroidectomy. The indications for parathyroidectomy included persistently elevated intact parathormone hormone le...

Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome
https://clinicaltrials.gov/ct2/show/NCT02854046

Sep 21st, 2021 - Calciphylaxis, also called Calcific Uremic Arteriolopathy (CUA) is a lethal affection mostly affecting patient in end stage renal disease. The survival rate is described around 20 to 46% at one year. Clinical presentation is very painful skin lesi...

Partners Calciphylaxis Biobank
https://clinicaltrials.gov/ct2/show/NCT03032835

Feb 24th, 2021 - Calciphylaxis, a vascular calcification disorder, is a rare and serious disorder characterized by calcification of dermal arterioles. There are significant gaps in the understanding of the pathophysiology and risk factors for calciphylaxis. At pre...

see more →

News  25 results

An Unusual Presentation of Calciphylaxis
https://www.mdedge.com/dermatology/article/219998/rare-diseases/unusual-presentation-calciphylaxis/page/0/1?channel=44

Apr 1st, 2020 - The pathogenesis of calciphylaxis is not well understood; however, some researchers suggest that an imbalance in calcium-phosphate homeostasis may lead to calciphylaxis; that is, elevated calcium and phosphate levels exceed their solubility and de.

An Unusual Presentation of Calciphylaxis
https://www.mdedge.com/dermatology/article/219998/rare-diseases/unusual-presentation-calciphylaxis
Jessica Garelik, DO, Vitaly Terushkin, MD et. al.

Apr 1st, 2020 - To the Editor: Calciphylaxis (also known as calcific uremic arteriolopathy and calcifying panniculitis) is a rare vasculopathy affecting the small vessels. 1 It is characterized by cutaneous ischemia and necrosis secondary to calcification.

Nonuremic Calciphylaxis Triggered by Rapid Weight Loss and Hypotension
https://www.mdedge.com/dermatology/article/216159/mixed-topics/nonuremic-calciphylaxis-triggered-rapid-weight-loss-and/page/0/1?channel=45

Jan 27th, 2020 - Comment Background on Calciphylaxis Calciphylaxis is a rare but deadly disease that affects both ESRD patients receiving dialysis and patients without ESRD who have known risk factors for calciphylaxis, including female gender, white race, obesity.

Hidradenitis Suppurativa for the Dermatologic Hospitalist
https://www.mdedge.com/dermatology/article/211561/rare-diseases/hidradenitis-suppurativa-dermatologic-hospitalist/page/0/1?channel=50892

Nov 5th, 2019 - Pearls for Inpatient and Emergency Evaluation and Management Initial Evaluation When dermatologic consultative services are asked to evaluate patients with HS, preliminary evaluation should reflect the acuity of the patient. Vital signs and toxici.

Outpatient Management and Follow-up Recommendations for Adverse Drug Reactions: Guidelines for Posthospitalization Care
https://www.mdedge.com/dermatology/article/200161/mixed-topics/outpatient-management-and-follow-recommendations-adverse/page/0/1?channel=50892

May 3rd, 2019 - Long-term Sequelae Endocrine Thyroid gland abnormalities secondary to DRESS syndrome include Graves disease and Hashimoto disease as well as variations in biomarkers including elevated free thyroxine and low and elevated thyroid-stimulating hormon.

see more →

Patient Education  1 results see all →